Women with higher blood levels of two widely used "forever chemicals" had a substantially higher incidence of an aggressive, harder-to-treat form of breast cancer, according to a National Institutes of Health analysis published earlier this month in the Journal of Clinical Oncology. The two compounds, perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS), belong to a class of synthetic chemicals known as PFAS that resist breaking down in the environment or the body, earning them the "forever chemical" nickname.
Researchers drew on the long-running Sister Study, which has tracked tens of thousands of women whose sisters had breast cancer, comparing blood samples — drawn years before any diagnosis — from 1,609 women who went on to develop breast cancer against a comparison group of 2,269 women who did not. Women with the highest blood levels of PFOA had a 67% higher rate of ER-negative breast cancer — a subtype that lacks the estrogen receptors many breast cancer drugs target, making it generally harder to treat — compared with women in the lowest exposure group. For PFOS, the rate was 93% higher, or nearly double. Crucially, the study found no clear association between either chemical and breast cancer risk overall, meaning the effect appears concentrated specifically in this more aggressive subtype rather than breast cancer broadly.
The researchers and outside experts cautioned that the figures describe relative differences between exposure groups, not a woman's absolute chance of developing the disease, and that an observational study like this one cannot prove the chemicals directly cause cancer rather than merely correlating with it. Both PFOA and PFOS have been largely phased out of US manufacturing over the past two decades after earlier health concerns, though they persist in soil, water and human blood for years after exposure ends; the study's lead author said further research is needed on the newer PFAS compounds that have since taken their place in many consumer products, since those replacements have not been studied as thoroughly and may carry their own unknown risks.